Lexeo Therapeutics Stock (NASDAQ: LXEO) stock price, news, charts, stock research, profile.
You can purchase shares of Lexeo Therapeutics (NASDAQ:LXEO) through any online brokerage.
Other companies in Lexeo Therapeutics’s space includes: Macrogenics (NASDAQ:MGNX), Molecular Partners (NASDAQ:MOLN), Invizyne Technologies (NASDAQ:IZTC), Precigen (NASDAQ:PGEN) and Zentalis Pharma (NASDAQ:ZNTL).
Lexeo Therapeutics has a consensus price target of $22.71.
The stock price for Lexeo Therapeutics (NASDAQ: LXEO) is $6.35 last updated December 24, 2024 at 1:01 PM EST.
There are no upcoming dividends for Lexeo Therapeutics.
Lexeo Therapeutics’s Q4 earnings are confirmed for Tuesday, January 7, 2025.
There is no upcoming split for Lexeo Therapeutics.
Lexeo Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.